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Abstract
Background: Plant GSK-3/Shaggy-like kinases are key players in brassinosteroid (BR) signalling which impact on
plant development and participate in response to wounding, pathogens and salt stress. Bikinin was previously
identified in a chemical genetics screen as an inhibitor targeting these kinases. To dissect the structural elements
crucial for inhibition of GSK-3/Shaggy-like kinases by bikinin and to isolate more potent compounds we synthesised
a number of related substances and tested their inhibitory activity in vitro and in vivo using Arabidopsis thaliana.
Results: A pyridine ring with an amido succinic acid residue in position 2 and a halogen in position 5 were crucial
for inhibitory activity. The compound with an iodine substituent in position 5, denoted iodobikinin, was most active
in inhibiting BIN2 activity in vitro and efficiently induced brassinosteroid-like responses in vivo. Its methyl ester,
methyliodobikinin, showed improved cell permeability, making it highly potent in vivo although it had lower activity
in vitro. HPLC analysis revealed that the methyl residue was rapidly cleaved off in planta liberating active iodobikinin.
In addition, we provide evidence that iodobikinin and bikinin are inactivated in planta by conjugation with glutamic
acid or malic acid and that the latter process is catalysed by the malate transferase SNG1.
Conclusion: Brassinosteroids participate in regulation of many aspects of plant development and in responses to
environmental cues. Thus compounds modulating their action are valuable tools to study such processes and may
be an interesting opportunity to modify plant growth and performance in horticulture and agronomy. Here we
report the development of bikinin derivatives with increased potency that can activate BR signalling and mimic BR
action. Methyliodobikinin was 3.4 times more active in vivo than bikinin. The main reason for the superior activity of
methyliodobikinin, the most potent compound, is its enhanced plant tissue permeability. Inactivation of bikinin and
its derivatives in planta involves SNG1, which constitutes a novel pathway for modification of xenobiotic
compounds.
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Background
Brassinosteroids (BRs) are plant steroid hormones in-
volved in many processes including cell expansion and
division, pollen tube growth, vascular tissue develop-
ment, senescence and modulation of stress responses
[1]. Plants deficient in brassinosteroids display character-
istic phenotypes including severe dwarfism, shortened
hypocotyls and round shaped dark green leaves. An
analysis of Arabidopsis thaliana mutants showing such
phenotypes revealed a number of enzymes crucial for
production of BRs. Depending on the affected pathway
these enzymes can be divided into two groups: the first
is involved in general sterol biosynthesis (Figure 1) and
includes DWF5 [2], STE1/DWF7 [3,4] and DWF1/CBB1
[5,6]. The second group includes DWF4 [7], CPD [8],
DET2 [9], ROT3, CYP90D1 [10], BR6ox1 and BR6ox2
[11]. These enzymes are involved in the BR biosynthesis
pathway that starts from the bulk sterol campesterol as a
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precursor and ultimately yields brassinolide (BL), the most
active BR (Figure 1). The expression of most enzymes of
the BR synthesis pathway is negatively regulated by BR
signalling while transcript levels of enzymes involved in
general sterol biosynthesis are not BR responsive.
BL is perceived by the receptor kinase BRI1 [12] and
its co-receptor BAK1 [13,14], which, unlike animal ster-
oid receptors, localise to the cell membrane. The signal
is transduced by the BSK group of receptor-like cyto-
plasmic kinases [15] and the phosphatase BSU1 [16] to
ASKs, A. thaliana GSK-3/Shaggy-like kinases, which are
inactivated in response to BL. ASKs are a family of
serine/threonine protein kinases that can be grouped
into four classes [17]. Several ASKs are involved BR sig-
nalling [16,18-21], some ASKs have been shown to play
a role in stress responses [22,23]. In the absence of BL
the ASKs are active and can phosphorylate a number of
transcription factors including BES1 [24], BZR1 [25] and
their homologues BEH1 to BEH4 [26], MYBL2 [27], SPCH
[28] and presumably also CES [29]. Interestingly, BIN2
(ASKη) and some other ASKs can also phosphorylate and
thereby inactivate YODA [30] and MKK4 [31], two protein
kinases acting in the MAP-kinase cascade that regulates
SPCH activity. Similar to YODA and MKK4 most tran-
scription factors are inhibited by BIN2-mediated phos-
phorylation. For instance, BES1 and BZR1 can only bind
DNA in their unphosphorylated form to regulate gene ex-
pression [21].
Although a number of enzymes involved in sterol and
BR synthesis and BR signalling are known, specific in-
hibitors are available only for a few of them (Figure 1).
Recently, the triazole derivative voriconazole was shown
to be a potent and specific inhibitor of plant CYP51s.
Plants treated with this compound showed significantly
reduced sterol and brassinosteroid levels and exhibited
the typical signs of BR deficiency [32].
The observation that the gibberellic acid biosynthesis
inhibitor uniconazole has a slight inhibitory effect on
brassinosteroid biosynthesis led to the development of
brassinazole [33] and Brz220 [34], two triazole deriva-
tives (Figure 1) that target the heme iron of cytochrome
P450 monooxygenase DWF4 [35,36]. Brassinazole has
Figure 1 Targets of inhibitors interfering with sterol biosynthesis, BR biosynthesis and BR signal transduction.
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widely been used to study the synthesis and effects of
brassinosteroids [37-41]. Furthermore, brassinazole was
employed in genetic screens to isolate mutants that do
not respond to this compound, which enabled the iden-
tification of the transcription factor BZR1 [25]. Several
other inhibitors of sterol/BR biosynthesis are also known
including Brz2001 [42], propiconazole [43], ketoconazole
[44] and itraconazole [32]. However their molecular tar-
gets have remained elusive.
High concentrations of lithium ions (~10 mM) are used
to inhibit the mammalian kinase GSK3β [45,46] and plant
ASKs [47-49]. However, lithium(I) lacks specificity [50]
and induces severe ion toxicity in plants [51-53], thus lim-
iting its value for in vivo studies. Bikinin was identified by
a chemical genetics approach as a compound that mimics
BL treatment [54]. Bikinin is a non-steroidal compound
that acts as an ATP-competitive inhibitor for plant GSK-3/
Shaggy-like kinases and thereby induces constitutive bras-
sinosteroid responses. Bikinin is the monoamide of succi-
nic acid with 2-amino-5-bromopyridine. The bromine in
position 5 of the pyridine ring and the carboxylic acid
group were recognised as being important for its activity
[54]. However, a more detailed structure-activity relation-
ship study to reveal the contribution of specific structural
elements, for instance length of the aliphatic side chain
and position of the heterocyclic nitrogen, is lacking and
preliminary data indicated that substitution of bromine by
other halogens might lead to more active compounds [54].
Here we studied the structural elements necessary for
bikinin activity in more detail, which allowed us to iso-
late derivatives with enhanced activity and, importantly,
increased cell-permeability. Moreover, we present evi-
dence for the catabolic fate of bikinin and its derivatives
after cellular uptake and identify a novel pathway for
modification of xenobiotic compounds.
Results
Synthesis
To gain more insight into the structural elements im-
portant for bikinin activity and to further improve biki-
nin inhibitor potency, we synthesised a set of bikinin
derivates. Bikinin and other derivatives were prepared by
formation of amides from substituted aminopyridines
and cyclic carboxylic acid anhydrides or chlorides of di-
carboxylic acid monomethyl esters (Additional file 1). In
the last case the methyl group was subsequently re-
moved by alkaline hydrolysis, if required. Determination
of the pKa of selected compounds revealed that they are
weak acids (Additional file 1).
In vitro inhibitor potency
Bikinin is a potent inhibitor of group I and group II ASKs.
ASKθ, a group III ASK is moderately inhibited. The sec-
ond kinase of this class, ASKβ, and the group IV kinase
ASKδ are not inhibited [54]. To investigate the inhibitor
activity of the set of bikinin derivates on ASK activity, rep-
resentatives of all four ASK groups were expressed as re-
combinant GST fusion proteins in E. coli and the potency
of the synthesised compounds (Figure 2) on the selected
ASKs was assayed by in vitro kinase assays using the com-
monly used artificial substrate myeline basic protein
(MBP) (Figure 3).
Compounds 1 to 5 were assayed to investigate the ef-
fect of length variation of the aliphatic side chain. The
most active compound, no. 3, had a chain consisting of 4
carbons (Figure 2). The glutaryl (no. 4; five carbons) and
the adipoyl (no. 5; six carbons) derivatives clearly had a
lower potency while the shorter derivatives (no. 1 and 2;
two and three carbons, respectively) had almost no effect.
Introduction of a double bond into a side chain of optimal
length abolished potency completely (Figure 3, compound
6) indicating that the steric conformation is highly import-
ant. To test whether the carboxy group of the aliphatic
chain is essential for activity or if an oxo group is suffi-
cient, we included compounds 9 and 10, which are the
methyl esters of compounds 3 and 15, respectively. Com-
pound 8, a structural isomer of compound 3, was also
tested (Figure 2). As shown in Figure 3, the methylated
variants showed dramatically reduced inhibitory effects
confirming that a terminal carboxy group is essential.
Having identified the optimal side chain, we next inves-
tigated the influence of the heterocyclic ring in more de-
tail. Compounds 3 and 11 both have an amido succinyl
side chain but differ in the position of the heterocyclic ni-
trogen. In vitro kinase assays revealed that compound 3 is
more potent (Figure 3), demonstrating that the heterocyc-
lic nitrogen must be adjacent to the position carrying the
amido succinic acid substituent.
Previous data indicated that a bromine substituent on
position 5 of the pyridine ring is critical for biological
activity of bikinin [54]. Compounds 12 to 16 were syn-
thesised to test the effect of other substituents. As indi-
cated in Figure 3 the chloro, bromo and especially the
iodo derivative were highly active while the fluoro com-
pound exhibited a very low potency. The unsubstituted
and the nitro derivatives were inactive. Quantification
of residual kinase activities showed that the inhibitory
effect on BIN2 increased with the atomic number of
the halogen substituent while an opposite but less pro-
nounced effect could be observed for ASKθ (Additional
file 2).
In summary, active derivatives inhibited ASKα, BIN2
and ASKζ strongly while ASKθ was moderately inhibited
and their effects on ASKβ and ASKδ were negligible.
Active compounds were characterised by an aliphatic C4
side chain with a terminal carboxy group and a hetero-
cyclic nitrogen next to the amido group. In addition, a
halogen substituent of the aromatic system was crucial.
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Figure 2 Structures of the synthesised compounds. The compounds 14 and 15 are also called bikinin (BIK) and iodobikinin, respectively. The
compounds 18 and 10, also called methylbikinin and methyliodobikinin, respectively, represent their methylesters.
Figure 3 In vitro inhibitor activity. For ASK in vitro kinase assays, purified GST-ASK fusion proteins were incubated with MBP as a substrate and
[γ-32P]-ATP as a co-substrate in absence (−) or presence of 10 μM of the different compounds (the numbers correspond to Figure 2). Compounds
1 to 9 (left panel) differ in the aliphatic side chain. The influence of the position of the heterocyclic nitrogen was tested with compounds 3 and
11 (middle panel; the molecular structure shown represents compound 11). The right panel shows the effect of the halogen substituent of the
pyridine ring. BIK, bikinin.
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A fluoro residue had only a slightly promotive effect while
the chloro, bromo and iodo derivatives were highly active.
In vivo effects of the inhibitors
Brassinosteroid deficient plants are severely dwarfed and
display dark green, epinastic leaves and shortened hypo-
cotyls. Application of 24-epi-brassinolide, a synthetic
brassinosteroid, can partially rescue BR biosynthesis mu-
tants like cpd [8] but does not change the phenotype of
BR signalling mutants like bri1-1 [55]. In contrast, biki-
nin can rescue both mutants partially [54]. To investi-
gate the in vivo potency of the synthesised derivatives
cpd and bri1-1 mutants were transferred to media sup-
plemented with these compounds. Seedlings treated with
active compounds showed expanded leaves, increased
hypocotyl lengths and were light green. The potency to
rescue the phenotype correlated with the results of the
in vitro assay except for compounds 10 (Figure 4A) and 9
(data not shown), which showed little potency in vitro but
were highly active in vivo. Because of this unexpected
result we compared the bioactivities of compound 15,
which has a free carboxy group terminal at its aliphatic
side chain, and of compound 10, which is the methylated
counterpart. In addition, we also synthesised compound
18, which is the methylated counterpart of bikinin (com-
pound 14). To obtain quantitative data we measured the
impact of these compounds on hypocotyl elongation of
A. thaliana, an assay frequently used to investigate BR
action [6,9,56]. The methylated compound 10 already
showed a clear effect on hypocotyl length at 10 μM, while
approximately 40 μM of compound 15 were necessary to
obtain comparable effects (Figure 4B). At such high con-
centrations compound 10 already showed toxic effects
that impeded full hypocotyl elongation. Similarly, methyl-
ated compounds 9 and 18 showed a much higher bio-
logical activity than their unmethylated counterparts 3
and 14 (bikinin), respectively (Additional file 3). We also
compared compound 10, the most active inhibior, and
bikinin (compound 14). Compound 10 and bikinin had
IC50 values (half maximal inhibitory concentrations) of 6.9
and 23.3 μM, respectively (Additional file 3C), showing
that compound 10 is 3.4 times more active in the hypo-
cotyl eleongation assay than the original bikinin.
Next we wanted to investigate the potency of the
methylated compounds at the molecular level. ASKs in-
volved in BR signalling downregulate the activity of
BES1/BZR1-family transcription factors by phosphoryl-
ation. This modification causes an electrophoretic mobil-
ity shift allowing convenient detection of in vivo ASK
activity by western blot analysis [20,24-26,54]. A. thaliana
seedlings expressing BZR1-CFP were treated with differ-
ent concentrations of compound 10 and 15 and the BZR1
phosphorylation pattern was compared by western blot
analysis with that of mock treated plants (Figure 4C). Both
compounds were capable to inducing a shift of BZR1-CFP
to its de-phosphorylated form. A comparable result
was also obtained for plants expressing BES1-CFP (Data
not shown). A similar shift was also seen in A. thaliana
protoplasts co-transformed with constructs of CFP-tagged
BZR1 and Myc-tagged ASKζ after treatment with dif-
ferent concentrations of compounds 10 and 15 (Additional
file 4).
Thus, surprisingly, the methylated derivatives 9, 18
and 10 showed similar or even higher activities in vivo
than their free acid counterparts 3, 14 and 15, respect-
ively, although in in vitro kinase assays the methyl esters
had a weaker effect on ASK activity.
Methylated bikinin derivatives are rapidly hydrolysed in
planta
To investigate these conflicting results in more detail,
we analysed the fate of compound 10 in vivo. Seedlings
were infiltrated with compound 10 and plant extracts
subsequently analysed by HPLC. Only trace amounts of
10 could be observed but a novel peak, designated P1,
appeared (Figures 5A and B). This peak could be identi-
fied by its retention time and its UV spectrum as com-
pound 15 (Figure 5 and Additional file 5) indicating that
compound 10 is rapidly converted to the highly active
compound 15 in planta and explaining the different
potency of compound 10 in vitro and in vivo. Prolonged
incubation led to formation of two additional peaks, desig-
nated P2 and P3 (Figure 5C and B). The spectra of these
two compounds indicate that they are derived from 15,
most likely by modification of the aliphatic side chain.
Similar results were obtained for the pairs 3/9 and 14/18
(data not shown).
Tissue permeability of bikinin derivatives
The previous result that the methylated compounds are
rapidly hydrolysed to their corresponding active free acid
forms provided an explanation for the observation that
the methylated compounds showed little or no activity
in vitro while they were highly active in vivo. However,
this result could not explain why the methylated deriva-
tives 10, 9 and 18 showed significantly higher in planta
activities than their free acid counterparts 15, 3 and 14,
respectively (Figure 4B and Additional file 3).
The cell-permeability of a substance is an important
characteristic for its in vivo potency. Thus, we deter-
mined the uptake of compounds 10 and 15 by treatment
of A. thaliana seedlings with the compounds and subse-
quent quantification of their internalised concentrations
(Figure 6). Since compound 10 is rapidly converted to
15, only the in situ concentration of the cleavage prod-
uct, compound 15, was measured. Uptake of both com-
pounds was rapid and the highest in situ concentrations
were observed after 3 hours of treatment. It is important
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to note that the plant internal concentrations exceeded
those of the medium. While 50 μM were present in the
medium, in situ concentrations of about 90 μM were
measured after treatment with compound 15 and more than
180 μM after treatment with compound 10. These data
show that the methylated inhibitor has an increased cell-
permeability as compared to its unmethylated analogue,
thus providing an explanation for the increased biological
activity of the methylated inhibitors.
Catabolic fate of bikinin derivatives
After prolonged inhibitor treatment the in situ concentra-
tion of compound 15 declined (Figure 6), concomitant
with the appearance of additional peaks that had already
been observed in the previous experiment (Figure 5D and
data not shown). According to the retention times and
UV spectra, the same end products, P2 and P3, were ob-
tained for compound 10 and 15 (data not shown).
Organisms can inactivate biologically active xenobiotic
compounds by a number of reactions including hydroly-
sis, oxidation or conjugation with metabolites. However,
it has also been reported that modification can activate a
previously inactive compound [57]. In order to investi-
gated whether the observed modification products of
compound 10, namely P1, which according to the previ-
ous results represents compound 15, and the two un-
known compounds P2 and P3, are potent to inhibit
ASKs, we purified the products by solid phase extraction
and two fractionations by HPLC. As expected from the
previous results (Figure 5 and Additional file 5), the UV
spectra of the isolated products P1, P2 and P3 were
nearly identical to that of the compounds 10 and 15
(data not shown) indicating that the chromophore, the
pyridine ring including the halogen substituent and the
amide bond, are still present in the products. This
allowed quantification of P1, P2 and P3 by HPLC and
UV detection. The potency of the isolated compounds
was subsequently investigated by in vitro kinase assays
(Figure 7). As previously determined, modification prod-
uct P1 of compound 10 was highly potent to inhibit
the kinase activity of BIN2. This was expected since
P1 represents compound 15. In contrast, the modifi-
cation products P2 and P3 had no impact on the activity
of BIN2.
A possible modification mechanism that could ex-
plain at least one of the additional peaks would be short-
ening of the side chain by β-oxidation, a pathway which
was first recognised by feeding experiments with synthetic
ω-phenyl fatty acids [58]. It has also been reported that
the plant growth regulator indole-3-butyric acid is acti-
vated in planta to indole-3-acetic acid (IAA) by a process
similar to β-oxidation [59]. To investigate whether P2 or
P3 originate from such a process we synthesised com-
pound 17, the expected β-oxidation end product of com-
pound 15 (Additional file 5A). However, the retention
time and the UV spectrum of compound 17 were distinct
from that of P2 or P3 (Additional file 5B and C), ruling
out this possibility.
To identify the metabolic products of compound 10,
we analysed them by high resolution mass-spectrometry.
Based on the obtained masses (Table 1) the only possible
chemical formula are C9H9IN2O3 for P1, C13H13IN2O7
for P2 and C14H16IN3O6 for P3. This confirms that P1 is
nearly identical to compound 15. Since P2 and P3 are
formed from P1 (=compound 15; C9H9IN2O3) and their
UV spectra are identical to that of compound 15, P2 and
P3 are presumably the conjugates of compound 15 with
glutamic (C5H9NO4) and malic acid (C4H6O5), respect-
ively (Figure 8). The observation of a conjugate with
glutamic acid was not surprising since the reaction of
amino acids with the carboxyl group of xenobiotics is a
widespread reaction in plants [60,61]. To provide add-
itional evidence for the composition of P2 we hydrolysed
an aliquot and performed amino acid analysis. In the
chromatogram a peak corresponding to glutamic acid was
clearly visible (Additional file 6), confirming that P2 is the
conjugate of compound 15 with glutamic acid.
SNG1 catalyses conjugation of bikinin derivatives with
malate
Intriguingly, besides the glutamic acid derivative we could
also detect a conjugate of compound 15 with malic acid.
While conjugates of xenobiotic compounds with malonic
and pyruvic acid are common, conjugates with malic acid
are less frequently observed [62] and the pathway for their
formation remains elusive.
The structure of the malic acid derivative of compound
15 (Figure 8) resembles that of sinapoylmalate, one of the
(See figure on previous page.)
Figure 4 In vivo effects of the inhibitors. (A) 7-day-old wild type A. thaliana seedlings, the brassinosteroid synthesis mutant cpd or the signalling
mutant bri1-1 were transferred to ½ MS medium containing 1 μM 24-epi-brassinolide (24-epi-BL), 30 μM compound 10 or 30 μM compound 15 and
incubated for 7 days under long day conditions. All pictures were taken with the same magnification. The size bar represents 1 mm. (B) The hypocotyl
length of 7-day-old A. thaliana Col-0 seedlings grown on ½ MS containing 1% sucrose and supplemented with compound 10 or 15 at the indicated
concentrations were measured. The means and standard deviations were calculated from at least 25 seedlings. (C) Plants expressing BZR1-CFP
were treated with the indicated compound for 1 h. Subsequently, the phosphorylation status of BZR1 was detected by western blot analysis
using a GFP-antibody. A coomassie R250 stain is shown as loading control.
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major soluble phenolic compounds present in A. thaliana.
Sinapoylmalate is synthesised by glucosylation of sinapic
acid by UGT84A2 and its homologues [63] and the subse-
quent exchange of the glucosyl residue to malate in a reac-
tion catalysed by SNG1 [64]. Because of functional
redundancy sinapoylglucose is still formed in ugt84a2
knock out plants [63]. In contrast, biosynthesis of sina-
poylmalate is blocked in sng1 mutants. To assess whether
the malate transferase SNG1 is necessary for generation of
P3, we treated sng1 seedlings with compound 10 and
Figure 5 Methylated compounds are rapidly hydrolysed in planta. A. thaliana Col-0 seedlings were infiltrated with a solution containing
50 μM compound 10. (A) Control samples were taken before infiltration and analysed by HPLC. (B) Already after 15 min a second peak designated
P1 appeared. (C) After 1 h two additional peaks, P2 and P3 were visible, (D) which became even more pronounced after 48 hours. (E) The same
experiment was performed with sng1 mutants. The chromatogram obtained with the sample taken after 48 h is shown. (F) Overlay of the 48 h
chromatograms of the Col-0 sample and the sng1 sample. The small boxes inserted into the chromatograms show the UV spectra of the
peaks in the range of 220 to 400 nm. SM, sinapoylmalate; SG, sinapoylglucose; mAU, milli absorption units recorded at 250 nm.
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analysed the plant extract by HPLC. While the glutamic
acid derivative P2 was still present, the malate deriva-
tive P3 was absent in plants deficient in SNG1 function
(Figures 5E and F), confirming that SNG1 catalyses forma-
tion of the latter. In the chromatogram of the sng1 plants
another peak appeared close to that of P3 while the
pronounced peak present at a retention time of 3.5 min
in extracts of Col-0 plants (see for instance Figure 5A)
was absent. These peaks showed strong fluorescence
(Additional file 7) and represent sinapoylglucose (reten-
tion time 7.5 min) and sinapoylmalate (retention time
3.5 min). In summary, this result demonstrates that SNG1
catalyses the conjugation of malate with compound 15.
Discussion
Mutants are widely and successfully used to investigate
different biological processes. The application of specific
inhibitors is an interesting alternative approach that may
offer several advantages compared to mutant analysis.
Inhibitors can be used in different genetic backgrounds
without the necessity for time consuming crossings.
Often they are active in a wide range of organisms allowing
investigation of species where no mutants are available. In
addition, the application of inhibitors can be limited to a
specific developmental stage. This is especially important if
a mutant is lethal. For instance, cyp51 knock out plants die
in early seedling stages [65] impeding dissection of the role
of CYP51 at later developmental stages. This problem
could be circumvented by using the specific CYP51
inhibitor voriconazole, which revealed that CYP51 is
highly important for providing precursors for BR biosyn-
thesis [32]. Another remarkable advantage of inhibitors
is that they can provide an opportunity to overcome
functional redundancy since homologous proteins are
often targeted by the same compound. This is especially
important for analysis of polyploid organisms but also for
gene families. For instance, A. thaliana encodes 10 ASKs
[17] with several of them involved in BR signalling [16,20].
While dominant gain of function mutants show severe
dwarfism [18,19], knock out mutants of single or even sev-
eral ASKs display no or only very slight phenotypes [21].
In contrast, plants treated with the ASK inhibitor bikinin
show the typical signs of constitutive BR response includ-
ing elongated hypocotyls and light-green leaves [54] indi-
cating that most or all ASKs crucial for BR signalling are
inhibited. As a consequence, bikinin has become a widely
used and valuable tool for studying BR signalling. Bikinin
was originally identified in a chemical genetics screen
for compounds mimicking BR responses. In vitro kin-
ase assays revealed that it inhibits ASK activity by com-
peting for the kinase binding site with ATP. Docking
simulations suggested that the heterocyclic nitrogen may
form a hydrogen bond with the backbone amide nitrogen
of a conserved valine residue (V118 in BIN2) located in
the ATP binding site [54]. This suggests that the hetero-
cyclic nitrogen is crucial for bikinin activity, which is in
perfect agreement with our results. Compound 11, which
differs from the highly active compound 3 only in the pos-
ition of the heterocyclic nitrogen, was inactive as revealed
by in vitro kinase assays. Previous results indicated that
the activity of the compounds decreases with the atomic
number of the halogen substituent in position 5 of the
pyridine ring [54]. However, we found that the fluoro de-
rivative (compound 12) showed little activity to inhibit any
ASK while the chloro, bromo and iodo derivatives were
highly potent (Figure 3). Interestingly, the inhibitory activ-
ity of the compounds on BIN2 increased slightly with the
atomic number of the halogen substituent while an oppos-
ite although weaker effect was seen for ASKθ (Additional
file 2). With respect to that it is important to note that
previous docking predictions indicate that the residue
interacting with bikinin is a methionine in BIN2 but a leu-
cine in ASKθ, which may explain the different potencies
of the chloro, bromo and iodo derivatives for these ASKs.
Analysis of a series of compounds differing only in the
length of the aliphatic side chain revealed that the in-
hibitory effect was highest with a side chain of 4 carbon
atoms and a terminal carboxy group (Figure 3). Previous
docking simulations indicated that the carboxy group is
necessary for interaction with an arginine conserved in
the ASKs (arginine R124 in BIN2) [54]. Since the car-
boxy group of the aliphatic chain of bikinin has a pKa of
5.6 (Additional file 1) it is negatively charged at the
intracellular pH. Thus it likely interacts with the posi-
tively charged arginine residue by ionic interactions. In
agreement with that the methylated derivatives 9 and 10,
which are uncharged at a physiological pH, showed little
Figure 6 Methylation increases tissue-permeability. A. thaliana
seedlings were incubated in 50 μM solutions of compounds 10 and
15 in ½ MS medium. Samples were taken after the indicated time
and the in situ levels of compound 15 were analysed by HPLC. The
solid line represents the results for plants incubated with compound
10 and the dashed line shows the results for compound 15.
The averages and standard deviations were calculated from 3
independent assays.
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activity in vitro. In sharp contrast to in vitro assays, the
methylated derivatives 9 and 10 were highly active
in vivo and partially rescued BR mutants. Hypocotyl
elongation, a typical response to BRs, was even more
strongly induced by compounds 9, 18 and 10 than their
free acid counterparts 3, 15 and 14 (Figure 4B and
Additional file 3). In addition, dephoshorylation of
BZR1, a widely used read out for BR signalling, was in-
duced by the methylated compound 15 to a similar or
higher extent than by the free acid compound 10, al-
though only the latter was capable of inhibiting ASKs
in vitro. The low in vitro effectiveness of the methylated
Figure 7 Activity of the modified compounds. The in planta modification products of compound 10 were isolated and assayed for their
potency to inhibit BIN2 activity in vitro. Compound 15 was used as a control. Each substance was used at a concentration of 10 μM. The
same conditions as in Figure 3 were applied except that [γ-33P]-ATP was used as co-substrate. A stain with coomassie R250 is included as
a loding control.
Table 1 UV and high resolution mass spectrometry
Compound UVmax [nm] m/z; deviation to the calculated m/z in ppm; ion type Calculated formula for [M]
10 250/292 334.9892; 1.5; [M + H]+ C10H11IN2O3
335.9921; 0.0; [13CM + H]+a
356.9708; 0.3; [M + Na]+
357.9742; 0.6; [13CM + Na]+
209.0920; 0.5; [M-I + H]+
210.0954; 0.0; [13CM-I + H]+
15 250/292 320.9735; 1.2; [M + H]+ C9H9IN2O3
321.9764; 0.0; [13CM + H]+
342.9551; 0.3; [M + Na]+
P1 251/292 320.9734; 0.9; [M + H]+ C9H9IN2O3
321.9766; 0.6; [13CM + H]+
342.9552; 0.6; [M + Na]+
P2 251/292 450.0163; 1.3; [M + H]+ C14H16IN3O6
451.0192; 0.4; [13CM + H]+
471.9978; 0.4; [M + Na]+
473.0012; 0.4; [13CM + Na]+
324.1192; 0.6; [M-I + H]+
325.1225; 0.3; [13CM-I + H]+
P3 251/292 436.9846; 1.4; [M + H]+ C13H13IN2O7
437.9876; 0.5; [13CM + H]+
458.9662; 0.4; [M + Na]+
459.9695; 0.4; [13CM + Na]+
311.0874; 0.6; [M-I + H]+
312.0907; 0.6; [13CM-I + H]+
a[13CM] means that the mother molecule contains one 13C carbon.
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inhibitors on the one hand and their high in vivo po-
tency on the other hand is likely due to their high
cellular permeability and the rapid cleavage of the
methyl residue in planta, probably by a lipase (peak P1 in
Figure 5).
Cellular uptake is a key factor determining inhibitor
potency. Tissue permeability assays revealed that up-
take of the compounds, especially methylated ones, was
rapid. Interestingly, the in situ concentrations exceeded
that of the surrounding medium several fold. This can be
explained by the pKa values of the compounds (Additional
file 1). For instance, derivative 15 has a pKa value of 5.8,
which means that at pH 5.8, the pH of the medium used,
50% of the compound are dissociated and therefore nega-
tively charged while 50% are undissociated. At the intra-
cellular pH of approximately 7.4 [66] less than 3% of the
compound is undissociated. Since only the undissociated,
lipophilic form is expected to pass biomembranes effi-
ciently, the compounds are trapped in the cell and
accumulate to concentrations exceeding that of the sur-
rounding medium. This pH-dependent uptake resembles
that of the plant hormone auxin, where pH-driven diffu-
sion has been suggested to contribute to transport into
the cell [67]. The esterified compounds, for instance com-
pound 10, are independent of the pH, highly lipophilic
and can pass membranes. In the cell they are rapidly
hydrolysed to the corresponding acids, which deprotonate
to hydrophilic anions. It is interesting to note that the up-
take rate of compound 10 was roughly double that of
compound 15, which correlates with the portions capable
of diffusion through the membrane: while 100% of com-
pound 10 are lipophilic, only 50% of compound 15 are un-
dissociated and therefore sufficiently lipophilic.
After prolonged incubation the in situ levels of com-
pound 15 declined, which was accompanied by the ap-
pearance of two peaks designated P2 and P3. The UV
spectra of these peaks were nearly identical to that of 15,
indicating that they contain the same chromophore,
namely the pyridine ring with the amido bond and the
halogen substituent. This, together with chemical for-
mulas determined by high resolution mass spectrom-
etry, revealed that P2 and P3 represent the glutamic and
malic acid derivatives of compound 15, respectively. While
conjugation of xenobiotic compounds with amino acids is
a common phenomenon [68], the formation of a conju-
gate with malic acid was intriguing. The structure of the
produced conjugate shows similarity to that of sinapoyl-
malate and thus we speculated that both compounds
might be formed by the same enzyme. Indeed, forma-
tion of the malate conjugate of compound 15 was abol-
ished in the sng1 mutant (Figures 5E and F). SNG1 is a
transferase catalysing the formation of sinapolymalate
Figure 8 The catabolic fate of compound 10 in A. thaliana. Compound 10 is rapidly hydrolysed, likely by a lipase, and thereby activated to
compound 15. Subsequently, compound 15 is inactivated by conjugation with glutamic acid or with malate. The latter reaction is catalysed by
SNG1. Since SNG1 utilises glucosylated substrates compound 15 is presumably glucosylated by a UGT prior to SNG1-mediated conjugation
with malate.
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from sinapoylglucose by exchange of the sugar residue
for malic acid. This suggests that compound 15 is gluco-
sylated in planta prior to conjugation with malic acid
(Figure 8) although we could not observe glucosylated
compound 15 in the chromatogram. In this respect it
is worth noting that sinapoylglucose is hardly detect-
able in Col-0 plants since, once formed, the glucose
residue is immediately exchanged to malate by SNG1, in-
dicating that, in a similar manner to sinapoylglucose, glu-
cosylated compound 15 might be rapidly metabolised.
Conclusion
The compounds 3, 14 and 15, were highly potent in vitro
with the iodo derivative (compound 15) showing the high-
est inhibitory effect on BIN2 and the chloro derivative
(compound 3) being most active against ASKθ. In vivo the
methylated counterparts were more active, since they were
significantly better taken up by plants and were immedi-
ately hydrolysed in planta to the active compounds. Thus,
we propose the methylated derivatives of bikinin as inhibi-
tors of choice for in vivo studies, especially if a rapid in-
hibition of ASKs is desired. Bikinin and its derivates are
only temporarily active in plants which might be useful to
dissect the role of ASK in a defined time window. The in-
activation of the inhibitors by conjugation with malate in-
volving SNG1 represents a novel pathway for modification
of xenobiotic compounds and opens up new directions for
studying the fate of xenobiotics in plants.
Methods
Synthesis of the compounds
The compounds were synthesised by reaction of amines
with carboxylic acid anhydrides or chlorides using the
methods described below. The reaction compounds and
yields of the products are listed in Additional file 1.
Method A: A solution of 25 mmol dicarboxylic acid
anhydride dissolved in 15 ml tetrahydrofuran (10 ml for
phthalic anhydride) was placed in a round bottom flask
equipped with a reflux condenser and 20 mmol amine
dissolved in 10 ml tetrahydrofuran was added. The mix-
ture was refluxed for 2 hours. The product started to crys-
tallise at the end of the reaction. Crystallisation was
completed by cooling to 4°C for several hours. The crude
product was filtered with suction and recrystallised from
95% ethanol except for the phthalic acid derivative, which
was recrystallised from 80% acetonitrile.
Method B: A solution of 20 mmol 2-amino-5-nitropyridine
dissolved in 30 ml tetrahydrofuran was placed in a round
bottom flask and 25 mmol solid succinic anhydride was
added. A reflux condenser was fitted to the flask and the
mixture heated to gentle boiling for 2 hours. Subse-
quently, the reaction mixture was cooled to −20°C for sev-
eral days. The crude product was filtered with suction and
recrystallised from hot water.
Method C: 20 mmol amine was dissolved in a mixture
of 40 ml tetrahydrofuran and 3.5 ml (25 mmol) triethyla-
mine and placed in a triple-necked round bottom flask
equipped with a reflux condenser, a dropping funnel and a
thermometer. The reaction mixture was agitated by mag-
netic stirring. A solution of 21 mmol acid chloride dis-
solved in 10 ml tetrahydrofuran was added slowly through
the dropping funnel at such a rate that the temperature
did not rise above 40°C. After the chloride had been
completely added, the reaction was stirred for further
15 minutes at room temperature. Subsequently, the mix-
ture was poured into 200 ml cold water and the pH set to
6 with diluted hydrochloric acid. The product was ex-
tracted three times with 50 ml diethylether and the com-
bined etheral extracts were washed with 50 ml 1% acetic
acid. Residual water was removed with anhydrous sodium
sulphate prior evaporation of the ether under reduced
pressure. The yellowish residue was recrystallised from
95% ethanol (chloro derivatives) or toluene (iodo deriva-
tive) to yield an almost white product.
Method D: 21 mmol acid chloride was dissolved in 10 ml
tetrahydrofuran and added to a solution of 20 mmol 2-
amino-5-chloropyridine in 3.5 ml (25 mmol) triethylamine
and 40 ml tetrahydrofuran as described in method C. The
mixture was stirred for 15 minutes prior to filtration to re-
move the triethylamine hydrochloride. The solid was
washed with 10 ml tetrahydrofuran and the combined fil-
trates evaporated under reduced pressure.
In the case of the oxalyl derivate, the residue was dis-
solved in 90 ml hot 95% ethanol and the solution was fil-
tered while still hot. The mixture was stirred and 40 mmol
KOH dissolved in 10 ml water was added at such a rate
that the temperature did not rise above 40°C. The reaction
was completed by stirring for a further 10 minutes. The
product separated as white potassium salt, which was col-
lected by suction. The precipitate was dissolved in 100 ml
(iodo derivative: 250 ml) hot water and filtrated. Hydro-
chloric acid was added to the hot filtrate until reaching
pH 2. The product separated as free acid during incubation
at 4°C overnight. The product was further purified by re-
crystallisation from 95% ethanol.
In the case of the malonyl and adipoyl derivatives, the
residue was dissolved in 200 ml MeOH and filtrated. The
solution was placed in a triple-necked round bottom flask
equipped with a reflux condenser, a dropping funnel and a
thermometer and heated to 50°C. While stirring the mix-
ture, 40 mmol KOH dissolved in 40 ml water was rapidly
added through the dropping funnel while the temperature
was maintained at 50°C. The reaction was completed by
stirring at the same temperature for an additional
10 minutes. The surplus of KOH was neutralised by the
addition of 40 mmol NH4Cl dissolved in 10 ml water.
Most of the solvent was removed under reduced pressure
and the residue was dissolved in water (about 200 ml) and
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filtered. Formic acid was added to the clear filtrate until
reaching pH 3. The product separated as white crystals
during incubation at 4°C overnight. The malonyl and adi-
poyl derivatives were purified by recrystallisation from
95% or 50% ethanol, respectively.
Determination of pKa values
Fifty to 100 mg of each compound were weighed and
dissolved in 50 ml 50% (v/v) methanol. A titration curve
with a 50 mM NaOH standard solution was recorded
with a Greisinger Electonics GPHR 1400A pH meter.
The equivalence point was determined by the difference
quotient method (ΔpH/ΔVNaOH) and the pKa read from
the titration curve at 50% neutralisation.
In vitro kinase assays
ASKs were expressed as GST-fusion proteins in Escheri-
chia coli BL21 as described previously [55]. In vitro kinase
assays were performed by incubating 50 ng GST-fusion
protein, 10 μg myelin basic protein (MBP; Sigma, St Louis,
MO) as a substrate and 0.15 MBq γ-[32P]-ATP as co-
substrate at 25°C for 30 min. The reaction buffer consisted
of 20 mM HEPES/KOH pH 7.4, 15 mM MgCl2, 5 mM
EGTA, 1 mM dithiothreitol and 1 μM cold ATP. The re-
action products were separated by SDS-PAGE and the
amount of radioactivity incorporated into MBP quantified
using an Amersham storage phosphor imager screen and
a Biorad Molecular Imager FX.
Physiological tests
Arabidopsis thaliana Col-0 or bri1-1 seedlings were
grown aseptically on ½ Murashige and Skoog (MS)
plates containing 0.8% agar and 1% sucrose in a growth
camber under long day conditions (16 h cool white
fluorescent light at a photon flux of 80 μmol · m−2 · s−1,
8 h dark) at 21°C for 7 days. Subsequently, they were
transferred to plates supplemented with inhibitors in dif-
ferent concentrations and effects on the phenotype were
observed 7 days later. For hypocotyl measurements Col-
0 seeds were plated on ½ MS plates containing the indi-
cated compounds, incubated at 4°C in the dark for 2 day
for stratification and subsequently transferred to long
day conditions. After 6 day hypocotyl length was mea-
sured using an Olympus SZX10 microscope at 10-fold
magnification.
Generation of lines transgenic for CFP tagged versions of
BZR1 or BES1
A. thaliana plants were transformed with the constructs
pGWR8-BZR1-CFP or pGWR8-BES1-CFP [20] by the
floral dip method [56]. For each transgene one line with
a representative subcellular BZR1 or BES1 expression
pattern was selected from at least 20 independent lines.
Western blot analysis
Plants transgenic for BZR1-CFP or BES1-CFP grown for
10 day on ½ MS medium containing 1% sucrose were
transferred to liquid medium and treated with the indi-
cated compounds for 2 h. Harvested samples (50 mg)
were shock-frozen in liquid nitrogen, homogenized with
a Retsch mill and after addition of 200 μl extraction buf-
fer (62.5 mM TRIS pH 6.8, 125 mM DTT, 2.5% SDS,
12.5% glycerol, 0.01% bromophenol blue) immediately
incubated at 95°C for 2 min. The samples were centri-
fuged at 15000 g for 5 min and 10 μl of the supernatants
separated by SDS-PAGE (10% gel) and blotted onto a
polyvinylidene difluoride membrane (Millipore, Billerica,
MA). The membrane was blocked with blocking buffer
(5% skim milk powder dissolved in 0.05% Tween 20,
150 mM NaCl and 10 mM TRIS/HCl pH 8.0) and subse-
quently probed with anti-GFP antibody (Roche, Basel,
Switzerland) diluted 1:5000 in blocking buffer. Alkaline
phosphatase-conjugated goat anti-mouse Fab specific
fragment (Sigma-Aldrich, St. Louis, MO, USA) diluted
1:5000 with blocking buffer was employed as secondary
antibody. For detection the CDP-Star™ detection reagent
(GE Healthcare, Buckinghamshire, UK) was used.
Protoplasts were transformed as described previously
[57] and treated with the indicated compounds for
1 h. After centrifugation, the protoplasts were lysed
by adding 10 μl 4× SDS loading buffer to 30 μl proto-
plast suspension and immediately heated to 95°C for
2 min. Western blot analysis was performed as described
above except that 20 μl protein extract were used for
SDS-PAGE.
Analysis of plant extracts by HPLC
Two-week-old A. thaliana Col-0 seedlings were vacuum
infiltrated with ½ MS or ½ MS containing 50 μM com-
pound 10 as described previously [58]. Samples were
taken at the indicated time points, rinsed with water and
ground in liquid nitrogen to a fine powder. 100 mg pow-
der was weighed into a reaction tube and 1 ml extraction
buffer (20% acetonitrile (ACN) containing 20 mM TRIS/
HCl pH 6.8) was added. After incubation for 30 min in a
shaker set to 800 rpm, the mixture was centrifuged and
the supernatant passed through a 0.2 μm filter and ana-
lysed by HPLC. The HPLC system comprised a Dionex
P680 pump, an ASI-100 autosampler and a PDA-100
photodiode array detector. The system was equipped with
a 250 × 4 mm Nucleosil 100–5 C18 250 × 4 mm column
(Macherey-Nagel, Düren, Germany) preceded by a Valco
2 μm inline-filter. A constant flow rate of 1 ml/min was
maintained with a gradient of solvent A (20 mM acetic
acid set to pH 4.8 with NaOH in 15% ACN) and solvent B
(20 mM acetic acid set to pH 4.8 with NaOH in 60%
ACN). Elution began with an isocratic flow of solvent A
for 1 min. The concentration of solvent B was then raised
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linearly to 100% within 19 min and kept isocratic for an-
other 2 min prior to reducing it to 0% within 1 min. The
column was equilibrated for 5 min with solvent A before
injection of the next sample. The UV spectra were re-
corded from 220 to 400 nm with 1 nm intervals. For
quantification the absorbance at 250 nm with a bandwidth
of 10 nm was recorded.
Cell-permeability assay
Two-week-old A. thaliana Col-0 seedlings were trans-
ferred to liquid ½ MS medium containing 50 μM inhibi-
tor. Samples were removed after the indicated time
points, rinsed twice with water, dried with filter paper
and frozen in liquid nitrogen. For analysis the plant mater-
ial was ground to a fine powder in a mortar pre-cooled
with liquid nitrogen. Approximately 100 mg powder was
weighed into 1.5 ml reaction tubes and 1 ml 20 mM
TRIS/HCl pH 8.0 added. 50 μl of a 200 μM stock of com-
pound 4 was added as internal standard. Extraction was
performed at 80°C for 30 min in an Eppendorf thermo
mixer set to 800 rpm. The extract was centrifuged for
5 min at 15000 g and the clear supernatant was collected.
The clear solution was acidified by addition of 25 μl 4 M
phosphoric acid and centrifuged for 2 min at 15000 g. The
supernatant was loaded immediately onto a PH 100 mg
solid-phase-extraction cartridge (Varian, Lake Forest, CA)
conditioned with 1 ml ACN and two times 1 ml 100 mM
phosphoric acid. Columns were washed with 1 ml 100 mM
phosphoric acid and dried by applying vacuum for 1 min.
Subsequently, elution was performed with 1 ml 100 mM
TRIS/HCl pH 9.0 containing 5% ACN. The eluate was acid-
ified by addition of 15 μl 4 M phosphoric acid and used for
HPLC as described above.
Isolation of modified compounds
Two-week-old A. thaliana Col-0 seedlings (600 mg) were
transferred to liquid ½ MS medium and compound 15
was added to a final concentration of 50 μM. After 48 h
incubation the plant material was collected, ground in li-
quid nitrogen to a fine powder and extracted as described
above. After centrifugation the clear supernatant was acid-
ified with 37.5 μl concentrated formic acid and loaded on
a 500 mg LiCrolute RP-18 conditioned with 3 ml ACN
and 3 ml water. The column was washed with 3 ml water
and eluted with 3 ml 50 mM TRIC/HCl pH 8.0 in 20%
ACN. The eluate was evaporated in the vacuum to dryness,
dissolved in 200 μl water and injected into a HPLC system
equipped with a Nucleosil 100–5 C18 200 × 4.6 mm
column (Macherey-Nagel, Düren, Germany) preceded by
a C18 4 × 3 mm Security Guard Cartridge (Phenomex,
Aschaffenburg, Germany). Elution was started with an iso-
cratic flow of 1 ml/min of solvent A (20 mM acetic acid
set to pH 4.8 with NaOH in 15% ACN) for 1 min before
the concentration of solvent B (20 mM acetic acid set to
pH 4.8 with NaOH in 60% ACN) was raised linearly to
60% over 19 min. Fractions were collected every 0.5 min
and analysed for the presence of modified compounds by
UV spectroscopy. Fractions containing the desired com-
pound were pooled, evaporated to dryness and the residue
was dissolved in 200 μl water and injected into the same
HPLC system described above except that elution was
performed with a linear gradient of 90% solvent A (0.1%
acetic acid in water) and 10% solvent B (80% ACN in
water) to 60% A and 40% B within 20 min at a constant
flow rate of 1 ml/min. Fractions were collected and proc-
essed in the same way as described above. After evapor-
ation the compounds were dissolved in 20 mM TRIS/HCl
pH 8.0. The concentrations were quantified by HPLC as
described above using compound 15 as a standard and
compound 14 as internal standard.
Liquid chromatography-high resolution mass
spectrometry
Collected eluates were separated by HPLC using a Hypersil
Gold C18 3 μm 150 × 2.1 mm column (Thermo Fischer
Scientific, Vienna, Austria) preceded by a C18 4 × 2 mm
guard column (Phenomex, Aschaffenburg, Germany). A
constant flow rate of 1 ml/min was maintained with a gra-
dient with eluent A (0.1% formic acid in water) and eluent
B (0.1% formic acid in ACN). Elution started isocratic with
90% A and 10% B for one minute. Subsequently, B was
linearly raised to 100% within 19 min and then kept at
100% for further 2 minutes prior reducing it to the start-
ing conditions within 0.1 min. The column was finally
equilibrated for 7.9 min with 90% A and 10% B before the
next sample was injected. For detection a LTQ Orbitrap
XL high-resolution mass spectrometer (Thermo Fisher
Scientific) was used. n-BBS (n-butylbenzenesulfonamide)
was constitutively present in our system and was used as
lock-mass ([n-BBS +H]+; m/z of 214.08963). Chemical
formulas were calculated with Xcalibur 2.1.1 with the fol-
lowing numbers of atoms: C: 0–30; H: 0–60; O: 1–10; N:
1–10; I: 0–2.
Amino acid analysis
Compound P2 was hydrolysed with 6 M hydrochloric acid
at 110°C for 4 h. The amino acid composition in the hy-
drolysate was analysed as described previously [59].
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